{"id":"W2085346499","doi":"10.1182/blood-2013-11-531327","title":"Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":638,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"National Cancer Institute; Teva Pharmaceutical Industries","keywords":"Bendamustine; Rituximab; Medicine; CHOP; Internal medicine; Oncology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006192997,0.0002845795,0.00164438,0.0001362929,0.00005235566,0.00001002035,0.0001200952,0.0000817929,0.0002282544],"category_scores_gemma":[0.000507033,0.0001193385,0.0003250394,0.0002451378,0.0001142598,0.00002729086,0.00004037547,0.00005719174,0.0000104395],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008311031,"about_ca_system_score_gemma":0.0001721062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001167251,"about_ca_topic_score_gemma":0.001216281,"domain_scores_codex":[0.9977539,0.0003157273,0.0009483516,0.0003236213,0.000407575,0.0002508443],"domain_scores_gemma":[0.9974532,0.001443978,0.0003145689,0.0006067184,0.0000887529,0.00009280299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8592901,0.1082013,0.01858292,0.00008890235,0.001445938,0.0001448589,0.002222738,0.000008490075,0.00003014655,0.00005420492,0.00007018659,0.009860264],"study_design_scores_gemma":[0.9631204,0.01436959,0.01202539,0.0001701507,0.002640802,0.00002781381,0.0001941792,0.00006049586,0.006355854,0.00002203467,0.0008985866,0.0001146877],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926395,0.0004793827,0.000004994025,0.0007693775,0.0001673606,0.005441647,0.00002486653,0.0000223637,0.0004505157],"genre_scores_gemma":[0.9976661,0.0005511417,0.0001273287,0.00005485913,0.0002457296,0.0008995655,0.00001690924,0.00002395384,0.0004143857],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1038304,"threshold_uncertainty_score":0.4866484,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03339717663584871,"score_gpt":0.3056359735912372,"score_spread":0.2722387969553885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}